Microscopic change may double breast cancer risk:
This article was originally published in Clinica
Executive Summary
A microscopic change in breast tissue could help doctors identify women at greater risk of developing breast cancer, according to a US study published in the New England Journal of Medicine (February 11). In a review of benign breast biopsies from nearly 1,400 women, researchers from the Beth Israel Deaconess Medical Center and Brigham and Women's Hospital in Boston found that those with a microscopic abnormality called a radial scar were twice as likely to develop the disease. Radial scars, which comprise a core of scar tissue surrounded by ducts, are sometimes detectable by mammography and have been linked to breast cancer in earlier studies.
You may also be interested in...
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.